血清代谢资料证据表明精神分裂症和抑郁症之间存在关联:一种非目标代谢学
Jing Zhang1, Ruru Ren2, Shuqin Ding2
1Traditional Chinese Medicine Hospital of Yinchuan, 231 Jiefang West Street, Yinchuan, 750001, China.
Biomedical chromatography : BMC
|October 22, 2024
概括
精神分裂症和抑郁症在氨酸/氨酸和氨酸/酸盐/酸盐路径中具有代谢相似性. 然而,在这些患者群体之间发现了N-乙黄胺,异乙甘氨酸和脂代谢的明显差异.
科学领域:
- 神经科学是一个神经科学.
- 代谢学 代谢学 代谢学
- 生物化学 生物化学
背景情况:
- 精神分裂症和抑郁症表现出遗传和临床重叠.
- 了解共同和独特的代谢概况对于差异性诊断和治疗至关重要.
研究的目的:
- 确定精神分裂症和抑郁症患者之间血清代谢概况的相似性和差异.
- 阐明这些疾病中涉及的共同和独特的代谢途径.
主要方法:
- 采用使用超高性能液体染色学四极点飞行时间质谱/质谱 (UHPLC-QTOF-MS/MS) 的全球代谢学.
- 分析了精神分裂症,抑郁症和健康对照患者的血清样本.
主要成果:
- 与对照组相比,分别在抑郁症和精神分裂症中确定了113个和118个不同的代谢物,其中94个是共享的代谢物.
- 氨酸和氨酸代谢,氨酸,酸盐和谷氨酸代谢是这两种疾病中常见的改变途径.
- 在血清N-乙谷氨胺和异乙甘氨酸水平中发现了显著的差异,并且脂代谢区分精神分裂症和抑郁症.
结论:
- 在精神分裂症和抑郁症中观察到氨酸/氨酸/氨酸/氨酸通路的共享代谢变化.
- 特定代谢物的明显差异 (N-乙谷氨胺,异乙甘油) 和脂代谢区分精神分裂症和抑郁症.
- 代谢分析提供了潜在的生物标志物,用于区分这些临床上重叠的精神疾病.
更多相关视频
05:14Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
Published on: September 8, 2021
3.3K
07:34Large Scale Non-targeted Metabolomic Profiling of Serum by Ultra Performance Liquid Chromatography-Mass Spectrometry UPLC-MS
Published on: March 14, 2013
12.7K
相关概念视频
Biological Causes of Schizophrenia
46
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
46
Depression: Overview
222
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
222
Psychological and Sociocultural Causes of Schizophrenia
80
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
80
Negative and Cognitive Symptoms of Schizophrenia
44
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
44
Antidepressant Drugs: MAOIs and Other Agents
196
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
196
